Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





New AI Research to Help Predict COVID-19 Resource Needs from Series of X-Rays

By HospiMedica International staff writers
Posted on 18 Jan 2021
Scientists have developed machine learning (ML) models that could help doctors predict how a COVID-19 patient’s condition may develop, in order to help hospitals ensure they have sufficient resources to care for patients.

Facebook AI (Menlo Park, CA, USA), in collaboration with NYU Langone Health’s Predictive Analytics Unit and Department of Radiology (Brooklyn, NY, USA) has developed three ML models that can help hospitals know whether COVID-19 patients are likely to need escalated treatment and plan accordingly. More...
The first ML model can predict patient deterioration based on a single X-ray and the second model can predict patient deterioration based on a sequence of X-rays, while the third model can predict how much supplemental oxygen (if any) a patient might need based on a single X-ray. Their model using sequential chest X-rays can predict up to four days (96 hours) in advance if a patient may need more intensive care solutions, generally outperforming predictions by human experts. These predictions could help doctors avoid sending at-risk patients home too soon, and help hospitals better predict demand for supplemental oxygen and other limited resources.

Previous approaches to this problem have relied on supervised training and used single timeframe images. While progress has been made with supervised training methods, labeling data is extremely time-intensive and thus limiting. The researchers chose instead to pretrain their ML system on two large, public chest X-ray data sets, MIMIC-CXR-JPG and CheXpert, using a self-supervised learning technique called Momentum Contrast (MoCo). This allowed them to use large amounts of non-COVID chest X-ray data to train a neural network that could extract information from chest X-ray images. Then the team fine-tuned the MoCo model using an extended version of the NYU COVID-19 data set.

MoCo relies on unsupervised learning using a contrastive loss function, mapping images to a latent space wherein similar images are mapped to vectors that are close together and dissimilar images to vectors that are further apart. These vectors can be used as feature representations, allowing one to train classifiers using a small number of labeled examples. Recent research shows that self-supervised learning using contrastive loss functions is effective in a variety of classification tasks. After pretraining the MoCo model on MIMIC-CXR-JPG and CheXpert, the researchers then used the pretrained model to build classifiers that could predict whether a COVID-19 patient’s condition is likely to deteriorate. The team used the NYU COVID chest X-ray data set for fine-tuning, as it contained 26,838 X-ray images taken from 4,914 patients. This smaller data set was labeled with whether the patient’s condition worsened within 24, 48, 72, or 96 hours of the scan in question.

The researchers built two kinds of classifiers to predict patient deterioration. The first model predicts patient deterioration based on a single X-ray in a fashion similar to a previous study. The second model predicts patient deterioration based on a sequence of X-rays by aggregating the image features via a Transformer model. Using self-supervised learning without having to rely on labeled data sets is crucial, as few research groups have enough COVID chest X-rays to train AI models. Building AI models that can use a sequence of X-rays for prediction purposes is particularly valuable because this method mirrors how human radiologists work, as using a sequence of X-rays is more accurate for long-term predictions. Importantly, this method also accounts for the evolution of COVID infections over time.

Based on reader studies conducted by Facebook AI researchers with radiologists at NYU Langone, their models that used sequences of X-ray images outperformed human experts at predicting ICU needs and mortality predictions, and overall adverse event predictions in the longer term (up to 96 hours). Being able to predict whether a patient will need oxygen resources would also be a first, and could help hospitals as they decide how to allocate resources in the weeks and months to come. With COVID-19 cases rising again across the world, hospitals need tools to predict and prepare for upcoming surges as they plan their resource allocations. These models could help in fight against COVID-19.

“We have been able to show that with the use of this AI algorithm, serial chest radiographs can predict the need for escalation of care in patients with COVID-19,” said William Moore, MD, a Professor of Radiology at NYU Langone Health. “As COVID-19 continues to be a major public health issue, the ability to predict a patient’s need for elevation of care - for example, ICU admission - will be essential for hospitals.”

Related Links:
Facebook AI
NYU Langone Health



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.